- Medical gases such as oxygen, nitrous oxide, medical air, and carbon dioxide are essential in patient care for anesthesia, ventilation, diagnostics, and therapy. These gases are administered through high-pressure cylinders or centralized systems and supported by gas equipment like flowmeters, regulators, vacuum systems, and manifolds.
- The growing burden of chronic diseases, increasing number of surgeries, and rising demand for emergency and home-based care are primary drivers. Rapidly aging populations and high pollution levels in urban centers have further pushed oxygen therapy adoption.
- China is the dominant country in the Asia-Pacific medical gas market due to its vast hospital infrastructure, high patient volumes, and government initiatives supporting medical infrastructure modernization.
- India is expected to register the highest CAGR in the region due to rapid urbanization, increased healthcare investments, and national programs promoting access to oxygen and critical care in tier-2 and tier-3 cities.
- Medical oxygen segment is expected to dominate the Asia-Pacific medical gas market with the largest market share of 53.2% due to its critical application in surgical procedures, respiratory illnesses, and emergency care. Increased investment in PSA oxygen plants and oxygen therapy awareness post-COVID further supports its leadership.
Frequently Asked Questions
India is expected to register the highest CAGR owing to national health infrastructure expansion and gas accessibility efforts
Distribution delays, rural infrastructure gaps, and limited biomedical workforce in underserved areas
Medical oxygen and high-pressure cylinders dominate due to their widespread use in acute and chronic care settings
